Epocrates

 
Drug and Disease Updates
DocAlert Messages:Editor's Picks
FDA MedWatch Safety Alerts
It's here! The Epocrates Update for Android
We Can Help with PQRI 2010
Epocrates Immunization Quick-Reference Lists
Safe Injection Practices: 5-Minute Refresher Course from CDC
Diseases and Conditions Highlight: Well-child care
What's This Disease?
 
 

Achoo!

Cold and flu season is here and Epocrates is here to support you as you help your patients get through it.

We include vaccination information, OTCs, drug-drug interaction checker and more in all our mobile Epocrates products. Plus, up-to-date disease and condition content, with well-child care highlighted below by Epocrates' Dr. Monique Yohanan.

Keep reading to discover what else Epocrates offers to ease this season's ills.

Share:

  Did you know?
In a recent survey, Epocrates asked healthcare professionals "Do you plan to receive, or have you already received a flu shot this year?" The results are in … and 80% answered "yes" and 20% answered "no". How about you? Tell us at youropinion@epocrates.com.

DocAlert Messages

Editor's Picks
Anne Meneghetti, MD
Director, Clinical Communications, Epocrates

Universal Influenza Vaccine Recommendations from CDC1


Routine vaccination with the combined seasonal flu and H1N1 flu vaccine is recommended for everyone aged 6 months and older. Additional principle updates include the following:

All children aged 6 months to 8 years receiving a seasonal influenza vaccine for the first time should receive 2 doses. Two doses are also appropriate for children aged 6 months to 8 years who are in their second flu vaccination year having received only one dose of seasonal flu vaccine during their first flu vaccination year, who did not receive any prior influenza A H1N1 2009 monovalent vaccine, or whose vaccine history (seasonal or influenza A H1N1 2009 monovalent) cannot be determined.
Expanded age ranges. Previously approved inactivated flu vaccines with expanded age indications include: Afluria®, now approved for people aged 6 months and older; and Fluarix®, now approved for people aged 3 years and older. A new inactivated influenza vaccine, Agriflu®, has been approved for people aged 18 years and older.
People age 65 and older have an alternative inactivated vaccine option containing higher doses of hemagglutinin antigen. Those 65 and older receiving an inactivated vaccine may receive any standard-dose trivalent inactivated influenza vaccine (TIV) or the recently approved Fluzone High-Dose® vaccine. Those under age 65 receiving inactivated influenza vaccine should receive standard-dose TIV.


Pneumococcal Vaccine Recommendation Updates from CDC2

Initial vaccination: 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) should be given to the following:

everyone at age 65 years
those 19-64 yo with immunosuppressive or chronic conditions (including asthma or other chronic lung disease, diabetes, alcoholism, liver disease; excluding hypertension)
cigarette smokers aged 19-64 yo (along with smoking cessation guidance)

Drug and Disease
Drugs
Share:

 

 
 

Routine PPSV23 use is no longer recommended for Alaskan Natives or Native Americans younger than 65 years old, unless they have medical indications for the vaccine.

Revaccination: The following should receive a second dose of PPSV23:

those who received PPSV23 before age 65 years (for any reason) should receive a second dose at age 65 or older (if more than 5 years have passed since the previous dose)

those 19-64 yo with immunosuppressive or chronic conditions (including asthma or other chronic lung disease, diabetes, alcoholism, liver disease; excluding hypertension)

Multiple PPSV23 revaccinations are not recommended, due to insufficient data regarding clinical benefit, degree and duration of protection, as well as safety.


1 MMWR July 29, 2010 / 59(Early Release);1-62
2 MMWR September 3, 2010 / 59(34);1102-1106


Share:

FDA Medwatch Safety Alerts

Prescription drugs: Meridia (sibutramine): Withdrawn due to cardiovascular risks, Bisphosphonates: Update on atypical fractures,  Invirase (saquinavir): Risk of abnormal heart rhythm, Fentanyl Transdermal System: Recall,  GnRH agonists: Increased risk of diabetes, CV disease,  Excelsior Medical saline flush syringes: Recall - potential loss of sterility, Lipitor (atorvastatin) 40 mg: Recall of specific bottles

OTC products: Hyland’s Teething Tablets: Recall - risk of belladonna toxicity, Tylenol 8 Hour Caplets: Recall, Slimming Beauty Bitter Orange Slimming Capsules: Undeclared drug ingredient

Medical devices: Huber Needles: Recall - risk of coring, CareFusion Corporation Alaris PC Units: Recall


Share:
 

What's new with Epocrates

It's here! The Epocrates Update for Android

Update today to get the new version of Epocrates Rx on Android®. It comes with increased speed, improved usability, plus requested features like the ability to sync, health plan formularies, over-the-counter drug products, and more.

How do you get it?

  Tap the Market icon and then the [Downloads] button
  Find Epocrates and tap it
  Tap the [Updates] button and follow the on-screen instructions

Join Now


Please note:

  Download time may take up to 30 minutes, depending on your connection. WiFi is strongly recommended.

  This application is for Android devices with v1.6 or higher. Check your version.

Share:



We Can Help with PQRI 2010

We know that Epocrates members strive to deliver outstanding patient care every day.

Did you know that the CMS PQRI program provides a financial incentive for practitioners who report on quality of care? Epocrates has partnered with Covisint DocSite.com to provide eligible professionals with a really quick and convenient way to participate.

Plus, Epocrates members save $100 on the submission fee!

Learn More >


Share:

Epocrates Immunization Quick-Reference Lists

Stay current with the latest CDC immunization guidelines through our quick-reference lists available free in Epocrates mobile and Epocrates® Online Premium products. Continually updated vaccination recommendations are available for adults, children (including accelerated and interval schedules), and travel.

Explore these quick-reference lists by entering "vaccination" or "immunization" in the Epocrates search bar on your mobile device or by browsing the Tables tab in Epocrates Online Premium. All Epocrates mobile products include over 60 vaccines, offering detailed information unique to each individual brand and generic product. Contact information for the national Vaccine Adverse Event Reporting System is found atop each vaccine monograph and in our convenient online reporting resource for clinicians.

Share:


Safe Injection Practices: 5-Minute Refresher Course from CDC

CDC has reported outbreaks of Hepatitis B and C in clinic settings, resulting from improper use of syringes, needles, and medication vials during injections. InICIDents like these result in notifying thousands of patients about possible bloodborne pathogen exposure, recommending that patients be tested for HCV, HBV, and HIV. With flu season upon us, now is a great time to brush up on safe injection practices.

Experience CDC: Injection Safety, a brief refresher course filled with images, short video clips, and safety tips. Access this activity anytime in the EssentialPoints™ list under the Epocrates "More" tab on iPhone®.



Diseases and Conditions Highlight: Well-child care

Monique Yohanan, MD, MPH
Physician Editor, Epocrates

The goals of well-child care are to maximize development, detect treatable diseases at an early stage, and prevent injury and disease through education. Recommendations include screening for cardiovascular risk factors (obesity, blood pressure, and dyslipidemia), providing anticipatory guidance for injury prevention and healthy growth and development, vision and hearing screening, and vaccinations.

Benefits of immunization include:
  complete or partial immunity against various infectious diseases,
  lower healthcare costs related to treatment of vaccine-preventable diseases,
  herd immunity
  reduced risk of disease outbreaks

Vaccine risks range from common, minor and local reactions to rare, potentially life-threatening adverse effects. Visit the complete monograph.


Share:
 


What's This Disease? Online
Test your knowledge!
Can you identify the disease in this image?

Answer

   
Find this image and many others in Epocrates® Essentials for iPhone® and BlackBerry®, Epocrates® Essentials Deluxe for iPhone and BlackBerry.
Log in to Epocrates Online for continually updated drug information and disease content and images.

Mobile Updates

Update (sync) your device regularly to download free clinical content and news, including new drugs and DocAlert messages.


We always love to hear from our members about Epocrates products or any other topic at youropinion@epocrates.com. We occasionally select reader comments to feature in future newsletters. All readers featured in the newsletter will receive a free one-year subscription to the premium product of their choice.


Email Us

Inquiries: Newsletter | Clinical | Suggestion | Newsletter Sign up

Technical: Email | Website

 
 
Epocrates Guarantee
Find us on Facebook Watch us on YouTube
Join us on Twitter  

Epocrates, Inc., 1100 Park Place Suite 300, San Mateo, CA 94403 www.epocrates.com